Researchers in the Henry Michtalik Lab are interested in patient safety—particularly as it relates to patient census statistics and acute to primary care transitions—and quality improvement and systems management.

The TIC works with interdisciplinary teams to bring digital health products to life in clinical settings at Johns Hopkins Health System. TIC offers design, development, business, and project management partnership to solve clinical problems that span the range of medical specialties and practice settings. Through community-based events and programs, the TIC also works to train the next wave of digital health innovators and builds start-up teams with the tools to launch commercial products improving patient care at Johns Hopkins and across the industry.

The key research interests in the Robert Bollinger Lab include identifying biological and behavioral risk factors for HIV transmission as well as characterizing the clinical progression and treatment of HIV and related infectious diseases. We also have a long-standing interest in optimizing health care capacity and delivery in settings with limited resources. Our work includes implementing science research projects to explore the effectiveness of initiatives such as task-shifting, clinical education, distance learning and mobile health programs as a way to improve health care in these locations.

Research in the Rahul Koka Lab focuses on pediatric airways, patient safety and health disparities. Recent studies have focused on the relationship between socioeconomic status and perioperative outcomes and patient safety factors related to interoperative cardiac arrests. We also performed effects analyses of the maintenance and repair of anesthetic equipment in various medical environments.

Research in the Rasika Mathias Lab focuses on the genetics of asthma in people of African ancestry. Our work led to the first genomewide association study of its kind in 2009. Currently, we are analyzing the whole-genome sequence of more than 1,000 people of African ancestry from the Consortium on Asthma among African-ancestry Populations in the Americas (CAAPA). CAAPA’s goal is to use whole-genome sequencing to expand our understanding of how genetic variants affect asthma risk in populations of African ancestry and to provide a public catalog of genetic variation for the scientific community. We’re also involved in the study of coronary artery disease though the GeneSTAR Program, which aims to identify mechanisms of atherogenic vascular diseases and attendant comorbidities.

Research in the Robert Gilman Lab focuses on disease control. Our work led to the development of microscopic-observation drug-susceptibility (MODS), a rapid tuberculosis diagnostic technique. We continue to conduct infectious disease research based at Peru’s Universidad Peruana Cayetano Heredia.

Research in the Raymond Reid Lab focuses on community health and pediatric infectious diseases among Native American populations; epidemiologic studies of enteric infections, Haemophilus influenzae, and pneumococcus; and field testing of vaccines and treatments.

The Advocacy and Research on Reproductive Wellness of Incarcerated People (ARRWIP) group was founded in 2017 by Dr. Carolyn Sufrin of Johns Hopkins Complex Family Planning Serivces. The goal of our research is to create opportunities to improve reproductive wellbeing for people affected by the criminal legal system – including making full-scope, compassionate reproductive health care accessible for people experiencing incarceration and advocating for alternatives to incarceration.

Research in the Romsai Boonyasai Lab focuses on systems-based approaches for improving health care quality, including reducing harm during care transitions after hospital discharge and improving outcomes related to hypertension and other chronic diseases. We recently have focused on developing and evaluating practice-based tools for improving the accuracy of blood pressure measurement, overcoming clinical inertia to treatment, and engaging patients in self-management of their health.

The Sydney Dy Lab has conducted extensive research on quality of care, patient safety and decision-making, with a focus on patients with cancer and other serious and terminal diseases. Our team seeks to improve health systems and services to optimize the use of technology and medication, particularly in end-of-life health care policy. Our research approach includes primary and quantitative data collection, quality measurement improvement, systematic literature reviews and analysis of secondary database.